Viewing Study NCT05060705


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-01-04 @ 2:54 AM
Study NCT ID: NCT05060705
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-17
First Post: 2021-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: "Efesovir" (FS-1) for COVID-19, Phase 2
Sponsor: Scientific Center for Anti-infectious Drugs, Kazakhstan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module